Outlook Therapeutics, Inc. (OTLK) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OTLK Revenue Growth
OTLK Revenue Analysis (2014–2025)
As of May 8, 2026, Outlook Therapeutics, Inc. (OTLK) generated trailing twelve-month (TTM) revenue of $205,535. The most recent quarter (Q1 2026) recorded $-1,208,000 in revenue.
Looking at the longer-term picture, OTLK's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $9.1 million in 2014.
When compared to Healthcare sector peers including ADVM (-100.0% YoY), and REGN (+5.9% YoY). Compare OTLK vs ADVM →
OTLK Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OTLKCurrent | $205,535 | - | - | -4744.3% | |
 ADVM | $1M | -100.0% | +32.0% | -13915.9% | |
 REGN | $14.3B | +5.9% | +11.0% | 24.9% |
OTLK Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.4M | - | $657K | 46.5% | $-67,061,666 | -4744.3% |
| 2024 | $0 | - | $-113,859 | - | $-71,703,000 | - |
| 2023 | $0 | - | $-44,188 | - | $-53,126,000 | - |
| 2022 | $0 | - | $-204,694 | - | $-63,071,000 | - |
| 2021 | $0 | - | $-262,139 | - | $-51,727,000 | - |
| 2020 | $0 | -100.0% | $-554,069 | - | $-36,841,000 | - |
| 2019 | $8.1M | +163.8% | $-15,659,000 | -192.2% | $-36,299,000 | -445.6% |
| 2018 | $3.1M | -19.0% | $0 | - | $-29,644,000 | -960.0% |
| 2017 | $3.8M | +27.9% | $0 | - | $-35,880,000 | -941.2% |
| 2016 | $3.0M | -42.9% | $0 | - | $-51,347,000 | -1723.1% |
See OTLK's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OTLK Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OTLK vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOTLK — Frequently Asked Questions
Quick answers to the most common questions about buying OTLK stock.
Is OTLK's revenue growth accelerating or slowing?
OTLK TTM revenue: $205535.00. YoY growth: N/A. 5-year CAGR: N/A.
What is OTLK's long-term revenue growth rate?
Outlook Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is OTLK's revenue distributed by segment?
OTLK reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.